ColombiaColombia is Latin America's third-largest pharmaceutical market, with a universal healthcare mandate driving sustained demand for medical devices, medicines, and wellness products. Taevas provides end-to-end regulatory, commercial, and distribution suppor
Select an industry to see regulatory pathways, services, and how Taevas supports your Colombia market entry.
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA)
Colombia's medical device sector is expanding rapidly, fuelled by a growing middle class and a government commitment to universal health coverage under the Sistema General de Seguridad Social en Salud. INVIMA classifies devices into four risk classes (I through IV) and requires a Registro Sanitario before any product may be imported or sold. Taevas manages the full registration lifecycle, from technical dossier preparation to post-market surveillance, giving international manufacturers a compliant and commercially ready pathway into Colombia.
Taevas prepares and submits the complete technical dossier to INVIMA under Decree 4725 of 2005, covering classification, labelling, and safety evidence. Timeline typically ranges from 3 to 12 months depending on device risk class.
Devices are classified Class I to IV based on intended use and patient risk. Taevas conducts a pre-submission classification analysis to select the correct pathway and avoid costly reclassification delays.
All regulated medical devices require an import licence issued by INVIMA prior to entry. Taevas coordinates with licensed importers, customs brokers, and freight forwarders to ensure seamless border clearance.
INVIMA requires ongoing pharmacovigilance reporting and periodic Registro Sanitario renewal every ten years. Taevas manages adverse event reporting, field safety corrective actions, and renewal submissions.
Taevas combines deep INVIMA regulatory expertise with an established commercial network across Colombia's 32 departments, giving international life-sciences brands a single accountable partner from first submission to sustained revenue growth.
Our Colombia regulatory team has navigated hundreds of Registro Sanitario applications across medical devices, pharmaceuticals, cosmetics, and food supplements, giving your brand a proven compliance advantage from day one.
Taevas operates across all 32 Colombian departments, with established distributor and logistics networks in Bogota, Medellin, Cali, Barranquilla, and secondary cities to maximise your commercial reach.
Our pre-submission review process and direct INVIMA relationships reduce dossier rejection rates and shorten approval timelines, so your product reaches Colombian healthcare professionals and consumers faster.
Taevas has pre-vetted distributor partnerships and relationships with leading Colombian KOLs across cardiology, oncology, dermatology, and nutrition, enabling credible and rapid market penetration for your brand.
Our Bogota-based team of regulatory affairs specialists, medical science liaisons, and commercial managers provides hands-on local support throughout your Colombia market entry journey.
Taevas has successfully launched life-sciences brands across multiple Latin American markets, with Colombia forming a central hub in our regional strategy and client success portfolio.
Speak with a Taevas Colombia specialist today to receive a tailored market entry assessment covering your regulatory pathway, timeline, and commercial strategy.